Pathstone Holdings »

Crinetics Pharmaceuticals In shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $953k 23k 41.65
2025-06-30 $727k 25k 28.76
2025-03-31 $950k 28k 33.54
2024-12-31 $1.0M 20k 51.13

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Driehaus Capital Management
Farallon Capital Management
EcoR1 Capital
Henderson Group
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
Jennison Associates
Point72 Asset Management
Siren
Novo A/S

View all funds holding Crinetics Pharmaceuticals In